Navigation Links
British study may improve glaucoma assessment and treatment

Rockville, MD Results from a recent scientific study in the U.K. may change the way that healthcare professionals measure eye pressure and allow them to assess the risk of glaucoma with greater accuracy. Glaucoma is the second most common cause of irreversible loss of vision worldwide.

The study, published in the Investigative Ophthalmology & Visual Science journal (Intraocular Pressure and Corneal Biomechanics in an Adult British Population -- The EPIC-Norfolk Eye Study), reports the distribution and causes of eye pressure -- medically termed intraocular pressure (IOP).

According to the authors, researchers have long recognized that the clinical methods of assessing eye pressure have suffered from some inaccuracies, specifically as a consequence of the physical properties of the cornea. The EPIC-Norfolk study presents the first large-scale population-based measures of corneal biomechanics.

"Previously, a rather crude measure -- central corneal thickness -- was used as an index of corneal biomechanics," said author Paul J. Foster, MD, PhD, FRCS(Ed), of the University College London Institute of Ophthalmology, "We used a device which generates measures of corneal biomechanics in conjunction with IOP and attempts to 'correct' IOP for corneal physical properties."

Recruited between 1993 and 1997, the EPIC-Norfolk cohort was made up of approximately 25,000 predominantly Caucasian men and women aged 40 to 79 living in eastern England. From 2006 to 2010, a health examination was conducted to objectively assess various physical, cognitive and ocular characteristics of participants. The research team used a non-contact tonometer, the Ocular Response Analyzer, to obtain eye pressure and corneal biomechanical data from 4,184 study participants, now aged 48 to 91 years.

"The accurate measurements of IOP and interpretation of the results in terms of what is seen in the 'normal' population are cardinal pieces of information when healthcare professionals conduct routine eye examinations," said Foster. "We will be using our results to assess the validity of current glaucoma treatment guidelines, with respect to levels of risk attributed to specific levels of IOP."

Contact: Katrina Norfleet
Association for Research in Vision and Ophthalmology

Related biology news :

1. The Royal Entomological Society Book of British Insects
2. Professor Cyrus Cooper awarded the Heberden Medal of the British Society for Rheumatology
3. Distribution of British soil bacteria mapped for the first time
4. Solar power systems could lighten the load for British soldiers
5. Roots of the British come under new scrutiny
6. British Indian children have better mental health
7. British scientific expedition discovers worlds deepest known undersea volcanic vents
8. Advances in cancer detection research by Virginia Tech engineer featured in British magazine
9. Springer signs agreement with British Society of Research on Ageing
10. British journal publishes inorganic chemistry research of NJIT professor
11. Scientists to sequence DNA of British wheat varieties
Post Your Comments:
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC , ... that the United States Patent and Trademark Office (USPTO) ... covers the linking of an iris image with a ... and represents the company,s 45 th issued patent. ... is very timely given the multi-modal biometric capabilities that ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
(Date:3/24/2017)... The Controller General of Immigration from Maldives Mr. Mohamed Anwar ... the prestigious international IAIR Award for the most innovative high security ePassport ... ... Maldives Immigration Controller General, Mr. ... on the right) have received the IAIR award for the "Most innovative ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity ... for performing systematic gain-of-function studies. , This complement to loss-of-function studies, such ...
(Date:10/11/2017)... ROTTERDAM, the Netherlands and LAGUNA HILLS, ... that The Institute of Cancer Research, London ... will use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify ... high-risk trial known as MUK nine . The University ... this trial, which is partly funded by Myeloma UK, and ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... process optimization firm for the life sciences and healthcare industries, announces a presentation ... San Francisco. , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will ...
Breaking Biology Technology: